Skip to content

Study on the effect of hysterosalpingography with opium poppy lipiodol on infertility patients

Real world study of hysterosalpingography with Ethiodized Poppyseed Oil in Chinese infertility treatment

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100041849
Enrollment
Unknown
Registered
2021-01-07
Start date
2021-03-01
Completion date
Unknown
Last updated
2021-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Interventions

Observation group:Hysterosalpingography with poppy lipiodol
Control group:Hysterosalpingography with ioverol

Sponsors

The Second Hospital of Hebei Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 42 Years

Inclusion criteria

Inclusion criteria: 1) Infertile patients; 2) Aged 18-42 years, female; 3) Have a spontaneous menstrual cycle; 4) Infertility for more than 12 months; 5) Meet the indications of hysterosalpingography; 6) Understand and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1) Iodine allergy; 2) Severe fallopian tube obstruction cannot be cleared; 3) Serious systemic diseases; 4) Within six weeks after pregnancy or uterine surgery.

Design outcomes

Primary

MeasureTime frame
Pregnancy;Live birth;Ectopic pregnancy;

Secondary

MeasureTime frame
Patency;

Countries

China

Contacts

Public ContactWei Wang

The Second Hospital of Hebei Medical University

wangwei_ivf@163.com+86 13832177339

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026